Eye Health News and Research

Latest Eye Health News and Research

Researchers win Jacob Heskel Gabbay Award in Biotechnology and Medicine

Karl Deisseroth of Stanford University, Gero Miesenb-ck of the University of Oxford and Edward S. Boyden of the Massachusetts Institute of Technology have been awarded Brandeis University's 16th Annual Jacob Heskel Gabbay Award in Biotechnology and Medicine.

22 Apr 2013

Penn researcher wins Distinguished Clinical Research Achievement Award for innovations in gene therapy

A gene therapy study focused on finding a cure for a rare congenital blinding disease has been recognized as one of the ten most outstanding clinical research projects of the year by the Clinical Research Forum (CRF).

22 Apr 2013

Bausch + Lomb agrees to commercialize Paragon BioTeck's phenylephrine in US

Bausch + Lomb, the global eye health company and Paragon BioTeck, Inc. today announced that the companies have entered into a license agreement for Bausch + Lomb to commercialize and distribute Paragon's phenylephrine in the United States on an exclusive basis beginning this month.

20 Apr 2013

Ceregene announces top-line data from CERE-12 Phase 2b clinical study for Parkinson's disease

Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin), a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease.

20 Apr 2013

Penn Medicine gene therapy study receives Distinguished Clinical Research Achievement Award

20 Apr 2013

Vision expo to offer rehabilitation information to blind and visually impaired patients

A daylong vision expo will be held Saturday, April 20 at the University of Houston (UH), offering information on rehabilitation and resources for the blind and visually impaired to live independent and productive lives.

19 Apr 2013

Arthritis drug reduces dry eye disease

Dry eye disease (DED) is a common condition that causes discomfort, visual disturbance and potentially damaging ocular surface inflammation that greatly impacts a person's quality of life.

19 Apr 2013

Financial leaders must recognize correlation between health, a strong economy

"Washington, D.C., is usually under the watchful eye of policy wonks and journalists. This weekend, however, the eyes of millions of children will be on D.C. as their fates are determined by the world's financial leaders, descending on Washington for the Spring Meetings of the IMF and World Bank," Ray Chambers, U.N. special envoy for health financing, writes in the Huffington Post's "Impact" blog.

19 Apr 2013

Obstructive salivary gland disease treatment: an interview with Thomas Cherry, Cook Medical

Everyone is familiar with urinary stones (kidney stones). The same thing can actually happen in your salivary ducts. These types of stones and strictures occur not nearly as frequently as kidney stones but they still occur quite often. The latest data we have seen showed about 1 in 5,000 patients actually have some type of obstructive salivary duct disorder.

From COOK MEDICAL INC. 19 Apr 2013

Research findings provide new hope for people suffering from dry eye disease

Natural lubricants play an important role in health, including a well-known effect to help prevent osteoarthritis in knee and ankle joints. However, much is still unknown about their role and function in other areas of the body.

19 Apr 2013

Scientists probe source of pulsing signal in the sleeping brain

New findings clarify where and how the brain's "slow waves" originate. These rhythmic signal pulses, which sweep through the brain during deep sleep at the rate of about one cycle per second, are assumed to play a role in processes such as consolidation of memory.

19 Apr 2013

Pediatric allergist offers tips to protect kids from allergies during the spring

Spring is having a hard time deciding if it wants to be here this year. Still, for many allergy sufferers its presence is being felt. Allergies are extremely common with an estimated 50 million people in the United States suffering from them.

19 Apr 2013

Arkansas' Medicaid expansion alternative survives bumpy path, gains state legislators' final approval

The GOP-controlled legislature narrowly approved the compromise that would use federal funds to buy private insurance for low-income residents.

19 Apr 2013

Dr. Jeffrey Maisels honored as 2013 Legends of Neonatology Hall of Fame inductee

M. Jeffrey Maisels, M.D., was honored as a 2013 Legends of Neonatology Hall of Fame inductee. He was chosen for a career spanning 47 years of clinical care and research involving management of the jaundiced newborn infant.

18 Apr 2013

Kaiser Permanente of the Mid-Atlantic States opens new South Baltimore County Medical Center

Kaiser Permanente of the Mid-Atlantic States, an award-winning not-for-profit health plan and care provider, opened the doors to its new South Baltimore County Medical Center on Monday, April 8, offering a vast array of medical services including around-the-clock urgent care, conveniently located under one roof.

18 Apr 2013

Tacere Therapeutics submits TT-034 clinical trial application to Recombinant DNA Advisory Committee

RNAi-based therapeutics company Benitec Biopharma Limited today announced that the company's wholly owned US subsidiary, Tacere Therapeutics Inc., has submitted an application to the US National Institutes of Health's Recombinant DNA Advisory Committee.

18 Apr 2013

University of Alberta researcher develops polymer platform technology for targeted drug delivery

A University of Alberta researcher is thinking small to find innovative ways to improve the delivery of drugs that can be more easily administered with fewer side-effects.

17 Apr 2013

Study shows driver fatigue causes 20% of road crashes

A 100-car naturalistic driving study conducted by the Virginia Tech Transportation Institute has shown that fatigue is a cause of 20 percent of crashes, rather than the 2 or 3 percent previously estimated based on surveys, simulator studies, and test tracks.

16 Apr 2013

Benitec to conduct phase I/II clinical trial of TT-034 in patients with HCV in UCSD site

RNAi-based therapeutics company Benitec Biopharma Limited today announced the selection of the University of California, San Diego, Health Sciences as the second site for its upcoming phase I/II first-in-man trial for TT-034 in Hepatitis C infections.

16 Apr 2013

Viewpoints: Editorial boards offer advice to Supreme Court on gene patents

On Monday, the Supreme Court is scheduled to hear argument about that decision in Association for Molecular Pathology v. Myriad Genetics.

16 Apr 2013

Eye Health News and Research

Latest Eye Health News and Research

Researchers win Jacob Heskel Gabbay Award in Biotechnology and Medicine

Penn researcher wins Distinguished Clinical Research Achievement Award for innovations in gene therapy

Bausch + Lomb agrees to commercialize Paragon BioTeck's phenylephrine in US

Ceregene announces top-line data from CERE-12 Phase 2b clinical study for Parkinson's disease

Penn Medicine gene therapy study receives Distinguished Clinical Research Achievement Award

Vision expo to offer rehabilitation information to blind and visually impaired patients

Arthritis drug reduces dry eye disease

Financial leaders must recognize correlation between health, a strong economy

Obstructive salivary gland disease treatment: an interview with Thomas Cherry, Cook Medical

Research findings provide new hope for people suffering from dry eye disease

Scientists probe source of pulsing signal in the sleeping brain

Pediatric allergist offers tips to protect kids from allergies during the spring

Arkansas' Medicaid expansion alternative survives bumpy path, gains state legislators' final approval

Dr. Jeffrey Maisels honored as 2013 Legends of Neonatology Hall of Fame inductee

Kaiser Permanente of the Mid-Atlantic States opens new South Baltimore County Medical Center

Tacere Therapeutics submits TT-034 clinical trial application to Recombinant DNA Advisory Committee

University of Alberta researcher develops polymer platform technology for targeted drug delivery

Study shows driver fatigue causes 20% of road crashes

Benitec to conduct phase I/II clinical trial of TT-034 in patients with HCV in UCSD site

Viewpoints: Editorial boards offer advice to Supreme Court on gene patents

Genetics & Genomics - Second Edition eBook

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Newsletters you may be interested in